EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus

Christina Karhan, Svenja M Sake, Melanie Urbanek-Quaing, Diletta Bergamo, Jessica Rückert, Jiabin Huang iD, Christina Grethe, Antonia P Gunesch, Anne Kühnel, Birthe Reinecke iD, Nicole Fischer, Thomas F Schulz und 2 weitere

ChemMedChem · 28.10.2026 · 21 (20)

DOI: 10.1002/cmdc.70501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 21.10.2026. Verfasst von Christina Karhan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Department of Pharmacy, Saarland Uni…. Hauptthemen laut MEDLINE: Antiviral Agents, Small Molecule Libraries, Respiratory Syncytial Viruses, Respiratory Syncytial Virus, Human. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VW-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) is a major cause of severe respiratory infections worldwide, particularly in infants, young children, and elderly individuals. Despite the availability of preventive options such as vaccines and monoclonal antibodies, effective antiviral therapies for acute infections remain limited. Therefore, we investigated small‐molecule entry inhibitors identified in a high‐throughput campaing and evaluated the most promising candidates in detail by performing resynthesis and determining their antiviral activity. Unfortunately, analytical investigations by nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography–mass spectrometry (LC–MS) revealed discrepancies between the screening samples and the resynthesized compounds for two compound classes, highlighting the complexity of hit validation and the potential influence of impurities. By publishing these results, we aim not only to underscore the importance of rigorous analytical and biological validation in screening campaigns but also to support the development of improved strategies for identifying reliable RSV inhibitors. We also believe it is important to publish false‐positive hits to avoid time efforts on projects that assume such compounds as genuine hits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSmall Molecule LibrariesRespiratory Syncytial VirusesRespiratory Syncytial Virus, HumanVirus InternalizationHumansStructure-Activity RelationshipHigh-Throughput Screening AssaysMolecular Structure

Stichwörter der Autor:innen

high‐throughput screeninghit validationrespiratory syncytial virus (RSV) entry inhibitorssmall molecules

Substanzen

Antiviral AgentsSmall Molecule Libraries

Autor:innen und Institutionen

  • Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Department of Pharmacy, Saarland University, Saarbrücken, Germany.
  • TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture Between the Helmholtz Centre for Infection Research and the Hannover Medical School, Hannover, Germany.
  • PharmaScienceHub (PSH), Saarland University, Saarbrücken, Germany.
  • Medizinische Hochschule Hannover-Institut für Virologie, MHH, Hannover, Germany.
  • Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Centre for Infection Research, Partner Site Hamburg-Borstel-Lübeck-Riems, Hamburg, Germany.

ORCID-Profile: Jiabin Huang, Birthe Reinecke, Thomas Pietschmann, Anna K H Hirsch

Förderung

  • VW-Stiftung

Zitieren

APA

Karhan, C., Sake, S. M., Urbanek-Quaing, M., Bergamo, D., Rückert, J., Huang, J., Grethe, C., Gunesch, A. P., Kühnel, A., Reinecke, B., Fischer, N., Schulz, T. F., Pietschmann, T., & Hirsch, A. K. H. (2026). Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70501

Vancouver

Karhan C, Sake SM, Urbanek-Quaing M, Bergamo D, Rückert J, Huang J, et al. Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70501

BibTeX
@article{Karhan2026,
  author = {Karhan, Christina and Sake, Svenja M and Urbanek-Quaing, Melanie and Bergamo, Diletta and Rückert, Jessica and Huang, Jiabin and Grethe, Christina and Gunesch, Antonia P and Kühnel, Anne and Reinecke, Birthe and Fischer, Nicole and Schulz, Thomas F and Pietschmann, Thomas and Hirsch, Anna K H},
  title = {Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70501}
}
Kostenlos starten →